Recent Research Analysts’ Ratings Changes for Arcadia Biosciences (RKDA)

A number of research firms have changed their ratings and price targets for Arcadia Biosciences (NASDAQ: RKDA):

• 4/13/2024 – Arcadia Biosciences is now covered by analysts at StockNews.com. They set a “sell” rating on the stock.
• 4/5/2024 – Arcadia Biosciences is now covered by analysts at StockNews.com. They set a “sell” rating on the stock.
• 4/5/2024 – Arcadia Biosciences had its “buy” rating reaffirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
• 3/28/2024 – Arcadia Biosciences is now covered by analysts at StockNews.com. They set a “sell” rating on the stock.
• 3/20/2024 – Arcadia Biosciences is now covered by analysts at StockNews.com. They set a “sell” rating on the stock.
• 3/12/2024 – Arcadia Biosciences is now covered by analysts at StockNews.com. They set a “sell” rating on the stock.
• 3/4/2024 – Arcadia Biosciences is now covered by analysts at StockNews.com. They set a “sell” rating on the stock.
• 2/25/2024 – Arcadia Biosciences is now covered by analysts at StockNews.com. They set a “sell” rating on the stock.

Arcadia Biosciences Trading Up 5.7 %

Arcadia Biosciences stock opened at $2.03 on Thursday. The business’s fifty day simple moving average is $2.45 and its two-hundred day simple moving average is $2.78. Arcadia Biosciences, Inc. has a 12 month low of $1.85 and a 12 month high of $7.30. The company has a market capitalization of $2.76 million, a price-to-earnings ratio of -0.14 and a beta of 0.60.

Institutional Investors Weigh In On Arcadia Biosciences

Several hedge funds have recently added to or reduced their stakes in RKDA. State Street Corp lifted its holdings in shares of Arcadia Biosciences by 76.7% during the first quarter. State Street Corp now owns 99,300 shares of the basic materials company’s stock valued at $139,000 after purchasing an additional 43,100 shares in the last quarter. Jane Street Group LLC lifted its holdings in shares of Arcadia Biosciences by 215.8% during the first quarter. Jane Street Group LLC now owns 36,458 shares of the basic materials company’s stock valued at $51,000 after purchasing an additional 24,913 shares in the last quarter. Renaissance Technologies LLC lifted its holdings in shares of Arcadia Biosciences by 66.5% during the second quarter. Renaissance Technologies LLC now owns 129,500 shares of the basic materials company’s stock valued at $130,000 after purchasing an additional 51,700 shares in the last quarter. Millennium Management LLC bought a new position in shares of Arcadia Biosciences during the second quarter valued at $25,000. Finally, Susquehanna International Group LLP lifted its holdings in shares of Arcadia Biosciences by 85.1% during the fourth quarter. Susquehanna International Group LLP now owns 282,419 shares of the basic materials company’s stock valued at $77,000 after purchasing an additional 129,811 shares in the last quarter. 17.73% of the stock is owned by institutional investors.

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.